Population screening is the process of assessing the prevalence of a particular trait in the entire population or in a subgroup of the population. Screening is the process of identifying healthy people who may have an increased chance of a disease or condition. The screening provider then offers information, further tests and treatment. This is to reduce associated problems or complications. Population screening is being adopted as a major strategy owing to benefits such as early patient identification, which can help reduce the burden of the higher treatment cost of diseases at later stages.
This report aims to provide a comprehensive presentation of the global market for Population Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Population Screening. This report contains market size and forecasts of Population Screening in global, including the following market information:
Global Population Screening Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Population Screening market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Hardware Equipment (Instrument, Kits, Chips) Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Population Screening include Agilent Technologies, Inc., ARUP Laboratories, F. Hoffmann-La Roche Ltd., Gene by Gene, Ltd., Illumina, Inc., QIAGEN, Quest Diagnostics, LGC Limited and Novogene Co., Ltd., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Population Screening companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Population Screening Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Population Screening Market Segment Percentages, by Type, 2022 (%)
Hardware Equipment (Instrument, Kits, Chips)
Testing / Lab (Services)
Analytics / Interpretation (Personalization And Interpretation)
Global Population Screening Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Population Screening Market Segment Percentages, by Application, 2022 (%)
Hospitals
Research Institutes
Diagnostic Labs
Global Population Screening Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Population Screening Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Population Screening revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Population Screening revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Agilent Technologies, Inc.
ARUP Laboratories
F. Hoffmann-La Roche Ltd.
Gene by Gene, Ltd.
Illumina, Inc.
QIAGEN
Quest Diagnostics
LGC Limited
Novogene Co., Ltd.
Thermo Fisher Scientific, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Population Screening, market overview.
Chapter 2: Global Population Screening market size in revenue.
Chapter 3: Detailed analysis of Population Screening company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Population Screening in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Population Screening Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Population Screening Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Population Screening Overall Market Size
2.1 Global Population Screening Market Size: 2022 VS 2032
2.2 Global Population Screening Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Population Screening Players in Global Market
3.2 Top Global Population Screening Companies Ranked by Revenue
3.3 Global Population Screening Revenue by Companies
3.4 Top 3 and Top 5 Population Screening Companies in Global Market, by Revenue in 2022
3.5 Global Companies Population Screening Product Type
3.6 Tier 1, Tier 2 and Tier 3 Population Screening Players in Global Market
3.6.1 List of Global Tier 1 Population Screening Companies
3.6.2 List of Global Tier 2 and Tier 3 Population Screening Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Population Screening Market Size Markets, 2022 & 2032
4.1.2 Hardware Equipment (Instrument, Kits, Chips)
4.1.3 Testing / Lab (Services)
4.1.4 Analytics / Interpretation (Personalization And Interpretation)
4.2 By Type - Global Population Screening Revenue & Forecasts
4.2.1 By Type - Global Population Screening Revenue, 2018-2023
4.2.2 By Type - Global Population Screening Revenue, 2024-2032
4.2.3 By Type - Global Population Screening Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Population Screening Market Size, 2022 & 2032
5.1.2 Hospitals
5.1.3 Research Institutes
5.1.4 Diagnostic Labs
5.2 By Application - Global Population Screening Revenue & Forecasts
5.2.1 By Application - Global Population Screening Revenue, 2018-2023
5.2.2 By Application - Global Population Screening Revenue, 2024-2032
5.2.3 By Application - Global Population Screening Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Population Screening Market Size, 2022 & 2032
6.2 By Region - Global Population Screening Revenue & Forecasts
6.2.1 By Region - Global Population Screening Revenue, 2018-2023
6.2.2 By Region - Global Population Screening Revenue, 2024-2032
6.2.3 By Region - Global Population Screening Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Population Screening Revenue, 2018-2032
6.3.2 US Population Screening Market Size, 2018-2032
6.3.3 Canada Population Screening Market Size, 2018-2032
6.3.4 Mexico Population Screening Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Population Screening Revenue, 2018-2032
6.4.2 Germany Population Screening Market Size, 2018-2032
6.4.3 France Population Screening Market Size, 2018-2032
6.4.4 U.K. Population Screening Market Size, 2018-2032
6.4.5 Italy Population Screening Market Size, 2018-2032
6.4.6 Russia Population Screening Market Size, 2018-2032
6.4.7 Nordic Countries Population Screening Market Size, 2018-2032
6.4.8 Benelux Population Screening Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Population Screening Revenue, 2018-2032
6.5.2 China Population Screening Market Size, 2018-2032
6.5.3 Japan Population Screening Market Size, 2018-2032
6.5.4 South Korea Population Screening Market Size, 2018-2032
6.5.5 Southeast Asia Population Screening Market Size, 2018-2032
6.5.6 India Population Screening Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Population Screening Revenue, 2018-2032
6.6.2 Brazil Population Screening Market Size, 2018-2032
6.6.3 Argentina Population Screening Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Population Screening Revenue, 2018-2032
6.7.2 Turkey Population Screening Market Size, 2018-2032
6.7.3 Israel Population Screening Market Size, 2018-2032
6.7.4 Saudi Arabia Population Screening Market Size, 2018-2032
6.7.5 UAE Population Screening Market Size, 2018-2032
7 Population Screening Companies Profiles
7.1 Agilent Technologies, Inc.
7.1.1 Agilent Technologies, Inc. Company Summary
7.1.2 Agilent Technologies, Inc. Business Overview
7.1.3 Agilent Technologies, Inc. Population Screening Major Product Offerings
7.1.4 Agilent Technologies, Inc. Population Screening Revenue in Global Market (2018-2023)
7.1.5 Agilent Technologies, Inc. Key News & Latest Developments
7.2 ARUP Laboratories
7.2.1 ARUP Laboratories Company Summary
7.2.2 ARUP Laboratories Business Overview
7.2.3 ARUP Laboratories Population Screening Major Product Offerings
7.2.4 ARUP Laboratories Population Screening Revenue in Global Market (2018-2023)
7.2.5 ARUP Laboratories Key News & Latest Developments
7.3 F. Hoffmann-La Roche Ltd.
7.3.1 F. Hoffmann-La Roche Ltd. Company Summary
7.3.2 F. Hoffmann-La Roche Ltd. Business Overview
7.3.3 F. Hoffmann-La Roche Ltd. Population Screening Major Product Offerings
7.3.4 F. Hoffmann-La Roche Ltd. Population Screening Revenue in Global Market (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.4 Gene by Gene, Ltd.
7.4.1 Gene by Gene, Ltd. Company Summary
7.4.2 Gene by Gene, Ltd. Business Overview
7.4.3 Gene by Gene, Ltd. Population Screening Major Product Offerings
7.4.4 Gene by Gene, Ltd. Population Screening Revenue in Global Market (2018-2023)
7.4.5 Gene by Gene, Ltd. Key News & Latest Developments
7.5 Illumina, Inc.
7.5.1 Illumina, Inc. Company Summary
7.5.2 Illumina, Inc. Business Overview
7.5.3 Illumina, Inc. Population Screening Major Product Offerings
7.5.4 Illumina, Inc. Population Screening Revenue in Global Market (2018-2023)
7.5.5 Illumina, Inc. Key News & Latest Developments
7.6 QIAGEN
7.6.1 QIAGEN Company Summary
7.6.2 QIAGEN Business Overview
7.6.3 QIAGEN Population Screening Major Product Offerings
7.6.4 QIAGEN Population Screening Revenue in Global Market (2018-2023)
7.6.5 QIAGEN Key News & Latest Developments
7.7 Quest Diagnostics
7.7.1 Quest Diagnostics Company Summary
7.7.2 Quest Diagnostics Business Overview
7.7.3 Quest Diagnostics Population Screening Major Product Offerings
7.7.4 Quest Diagnostics Population Screening Revenue in Global Market (2018-2023)
7.7.5 Quest Diagnostics Key News & Latest Developments
7.8 LGC Limited
7.8.1 LGC Limited Company Summary
7.8.2 LGC Limited Business Overview
7.8.3 LGC Limited Population Screening Major Product Offerings
7.8.4 LGC Limited Population Screening Revenue in Global Market (2018-2023)
7.8.5 LGC Limited Key News & Latest Developments
7.9 Novogene Co., Ltd.
7.9.1 Novogene Co., Ltd. Company Summary
7.9.2 Novogene Co., Ltd. Business Overview
7.9.3 Novogene Co., Ltd. Population Screening Major Product Offerings
7.9.4 Novogene Co., Ltd. Population Screening Revenue in Global Market (2018-2023)
7.9.5 Novogene Co., Ltd. Key News & Latest Developments
7.10 Thermo Fisher Scientific, Inc.
7.10.1 Thermo Fisher Scientific, Inc. Company Summary
7.10.2 Thermo Fisher Scientific, Inc. Business Overview
7.10.3 Thermo Fisher Scientific, Inc. Population Screening Major Product Offerings
7.10.4 Thermo Fisher Scientific, Inc. Population Screening Revenue in Global Market (2018-2023)
7.10.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Population Screening Market Opportunities & Trends in Global Market
Table 2. Population Screening Market Drivers in Global Market
Table 3. Population Screening Market Restraints in Global Market
Table 4. Key Players of Population Screening in Global Market
Table 5. Top Population Screening Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Population Screening Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Population Screening Revenue Share by Companies, 2018-2023
Table 8. Global Companies Population Screening Product Type
Table 9. List of Global Tier 1 Population Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Population Screening Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Population Screening Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Population Screening Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Population Screening Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Population Screening Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Population Screening Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Population Screening Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Population Screening Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Population Screening Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Population Screening Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Population Screening Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Population Screening Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Population Screening Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Population Screening Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Population Screening Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Population Screening Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Population Screening Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Population Screening Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Population Screening Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Population Screening Revenue, (US$, Mn), 2024-2032
Table 30. Agilent Technologies, Inc. Company Summary
Table 31. Agilent Technologies, Inc. Population Screening Product Offerings
Table 32. Agilent Technologies, Inc. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 33. Agilent Technologies, Inc. Key News & Latest Developments
Table 34. ARUP Laboratories Company Summary
Table 35. ARUP Laboratories Population Screening Product Offerings
Table 36. ARUP Laboratories Population Screening Revenue (US$, Mn) & (2018-2023)
Table 37. ARUP Laboratories Key News & Latest Developments
Table 38. F. Hoffmann-La Roche Ltd. Company Summary
Table 39. F. Hoffmann-La Roche Ltd. Population Screening Product Offerings
Table 40. F. Hoffmann-La Roche Ltd. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 41. F. Hoffmann-La Roche Ltd. Key News & Latest Developments
Table 42. Gene by Gene, Ltd. Company Summary
Table 43. Gene by Gene, Ltd. Population Screening Product Offerings
Table 44. Gene by Gene, Ltd. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 45. Gene by Gene, Ltd. Key News & Latest Developments
Table 46. Illumina, Inc. Company Summary
Table 47. Illumina, Inc. Population Screening Product Offerings
Table 48. Illumina, Inc. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 49. Illumina, Inc. Key News & Latest Developments
Table 50. QIAGEN Company Summary
Table 51. QIAGEN Population Screening Product Offerings
Table 52. QIAGEN Population Screening Revenue (US$, Mn) & (2018-2023)
Table 53. QIAGEN Key News & Latest Developments
Table 54. Quest Diagnostics Company Summary
Table 55. Quest Diagnostics Population Screening Product Offerings
Table 56. Quest Diagnostics Population Screening Revenue (US$, Mn) & (2018-2023)
Table 57. Quest Diagnostics Key News & Latest Developments
Table 58. LGC Limited Company Summary
Table 59. LGC Limited Population Screening Product Offerings
Table 60. LGC Limited Population Screening Revenue (US$, Mn) & (2018-2023)
Table 61. LGC Limited Key News & Latest Developments
Table 62. Novogene Co., Ltd. Company Summary
Table 63. Novogene Co., Ltd. Population Screening Product Offerings
Table 64. Novogene Co., Ltd. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 65. Novogene Co., Ltd. Key News & Latest Developments
Table 66. Thermo Fisher Scientific, Inc. Company Summary
Table 67. Thermo Fisher Scientific, Inc. Population Screening Product Offerings
Table 68. Thermo Fisher Scientific, Inc. Population Screening Revenue (US$, Mn) & (2018-2023)
Table 69. Thermo Fisher Scientific, Inc. Key News & Latest Developments
List of Figures
Figure 1. Population Screening Segment by Type in 2022
Figure 2. Population Screening Segment by Application in 2022
Figure 3. Global Population Screening Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Population Screening Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Population Screening Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Population Screening Revenue in 2022
Figure 8. By Type - Global Population Screening Revenue Market Share, 2018-2032
Figure 9. By Application - Global Population Screening Revenue Market Share, 2018-2032
Figure 10. By Type - Global Population Screening Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Population Screening Revenue Market Share, 2018-2032
Figure 12. By Application - Global Population Screening Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Population Screening Revenue Market Share, 2018-2032
Figure 14. By Region - Global Population Screening Revenue Market Share, 2018-2032
Figure 15. By Country - North America Population Screening Revenue Market Share, 2018-2032
Figure 16. US Population Screening Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Population Screening Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Population Screening Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Population Screening Revenue Market Share, 2018-2032
Figure 20. Germany Population Screening Revenue, (US$, Mn), 2018-2032
Figure 21. France Population Screening Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Population Screening Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Population Screening Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Population Screening Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Population Screening Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Population Screening Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Population Screening Revenue Market Share, 2018-2032
Figure 28. China Population Screening Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Population Screening Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Population Screening Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Population Screening Revenue, (US$, Mn), 2018-2032
Figure 32. India Population Screening Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Population Screening Revenue Market Share, 2018-2032
Figure 34. Brazil Population Screening Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Population Screening Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Population Screening Revenue Market Share, 2018-2032
Figure 37. Turkey Population Screening Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Population Screening Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Population Screening Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Population Screening Revenue, (US$, Mn), 2018-2032
Figure 41. Agilent Technologies, Inc. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. ARUP Laboratories Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. F. Hoffmann-La Roche Ltd. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Gene by Gene, Ltd. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Illumina, Inc. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. QIAGEN Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Quest Diagnostics Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. LGC Limited Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novogene Co., Ltd. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Thermo Fisher Scientific, Inc. Population Screening Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
